These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38481280)

  • 1. A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer's disease.
    Zhang Y; Xue L; Zhang S; Yang J; Zhang Q; Wang M; Wang L; Zhang M; Jiang J; Li Y;
    Alzheimers Res Ther; 2024 Mar; 16(1):60. PubMed ID: 38481280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early prediction of dementia using fMRI data with a graph convolutional network approach.
    Han S; Sun Z; Zhao K; Duan F; Caiafa CF; Zhang Y; Solé-Casals J
    J Neural Eng; 2024 Jan; 21(1):. PubMed ID: 38215493
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated classification of Alzheimer's disease, mild cognitive impairment, and cognitively normal patients using 3D convolutional neural network and radiomic features from T1-weighted brain MRI: A comparative study on detection accuracy.
    Zarei A; Keshavarz A; Jafari E; Nemati R; Farhadi A; Gholamrezanezhad A; Rostami H; Assadi M
    Clin Imaging; 2024 Nov; 115():110301. PubMed ID: 39303405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An extensible hierarchical graph convolutional network for early Alzheimer's disease identification.
    Tian X; Liu Y; Wang L; Zeng X; Huang Y; Wang Z
    Comput Methods Programs Biomed; 2023 Aug; 238():107597. PubMed ID: 37216716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
    Ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F
    Alzheimers Res Ther; 2018 Sep; 10(1):100. PubMed ID: 30261928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Default-Mode Network Connectivity Changes During the Progression Toward Alzheimer's Dementia: A Longitudinal Functional Magnetic Resonance Imaging Study.
    Malotaux V; Dricot L; Quenon L; Lhommel R; Ivanoiu A; Hanseeuw B
    Brain Connect; 2023 Jun; 13(5):287-296. PubMed ID: 36103377
    [No Abstract]   [Full Text] [Related]  

  • 7. Temporal and Spatial Analysis of Alzheimer's Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network.
    Sun H; Wang A; He S
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted Balance of Gray Matter Volume and Directed Functional Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
    Xiong Y; Ye C; Sun R; Chen Y; Zhong X; Zhang J; Zhong Z; Chen H; Huang M
    Curr Alzheimer Res; 2023; 20(3):161-174. PubMed ID: 37278043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does resting state functional connectivity differ between mild cognitive impairment and early Alzheimer's dementia?
    Soman SM; Raghavan S; Rajesh PG; Mohanan N; Thomas B; Kesavadas C; Menon RN
    J Neurol Sci; 2020 Nov; 418():117093. PubMed ID: 32827882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Connectome Analysis in Mild Cognitive Impairment: Comparing Alzheimer's Disease Continuum and Suspected Non-Alzheimer Pathology.
    Brandes Lourenço R; Machado de Campos B; Rizzi L; Sakzenian de Souza M; Forlenza OV; Giroud Joaquim H; Leme Talib L; Cendes F; Figueredo Balthazar ML
    Brain Connect; 2022 Nov; 12(9):774-783. PubMed ID: 35412854
    [No Abstract]   [Full Text] [Related]  

  • 12. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.
    Moradi E; Pepe A; Gaser C; Huttunen H; Tohka J;
    Neuroimage; 2015 Jan; 104():398-412. PubMed ID: 25312773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
    Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
    Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
    Zhou Y; Yu F; Duong TQ;
    J Magn Reson Imaging; 2015 Jan; 41(1):102-9. PubMed ID: 24382798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.
    Park MK; Ahn J; Kim YJ; Lee JW; Lee JC; Hwang SJ; Kim KC
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Graph Convolutional Network Based on Univariate Neurodegeneration Biomarker for Alzheimer's Disease Diagnosis.
    Qu Z; Yao T; Liu X; Wang G
    IEEE J Transl Eng Health Med; 2023; 11():405-416. PubMed ID: 37492469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
    Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
    Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.